-
Two Algorithms Can ID Patients at Risk for HIV, PrEP Candidates
drugs
July 11, 2019
Two new research papers, published online in The Lancet HIV, present algorithms that can help identify patients at risk for HIV and candidates for preexposure prophylaxis (PrEP).
-
Mylan, Atomo Announce WHO Prequalification Approval for HIV Self Test
americanpharmaceuticalreview
July 09, 2019
Mylan and medical device manufacturer Atomo Diagnostics announced the Mylan HIV Self Test, a handheld in vitro HIV rapid diagnostic test for self-testing, has received Prequalification approval by the World Health Organization (WHO PQ).
-
CRISPR study offers hope for potential HIV cure
pharmaceutical-technology
July 05, 2019
A study by US researchers has used a genetic editing technology to eliminate replication-competent HIV-1 DNA from the genomes of living animals, offering hope for a potential cure in humans.
-
Most Americans Have Never Had an HIV Test: CDC
drugs
July 01, 2019
Most Americans Have Never Had an HIV Test.
-
Less Than 40 Percent of All U.S. Adults Have Ever Had HIV Testing
drugs
June 28, 2019
Less Than 40 Percent of All U.S. Adults Have Ever Had HIV Testing.
-
HIV Risk Does Not Differ With Three Contraceptive Methods
drugs
June 14, 2019
HIV Risk Does Not Differ With Three Contraceptive Methods.
-
USPSTF Issues Recommendations on HIV Screening, Prevention
drugs
June 12, 2019
USPSTF Issues Recommendations on HIV Screening, Prevention.
-
Guidelines Issued for Addressing Heart Disease Risk in HIV
drugs
June 04, 2019
Guidelines Issued for Addressing Heart Disease Risk in HIV.
-
HIV Patients More Likely to Have Heart Troubles, But Less Access to Care
drugs
June 04, 2019
HIV Patients More Likely to Have Heart Troubles, But Less Access to Care.
-
Stepped Tx for Alcohol Use Disorder Studied in HIV Patients
drugs
May 31, 2019
Stepped Tx for Alcohol Use Disorder Studied in HIV Patients.